Improved efficacy of fluconazole against candidiasis using bio‐based microemulsion technique
- 4 April 2013
- journal article
- research article
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 60 (4) , 417-429
Abstract
Candida albicans is a common fungal pathogen that causes systemic and superficial infections in most immunocompromised patients. Fluconazole, a synthetic triazole antifungal agent, is the most prescribed drug used in treating this pathogen. But because of its poor solubilization in water and the emergence of resistant strains against this antimycotic drug, we aimed at devising a unique microemulsion drug delivery system for fluconazole against candidiasis. A clear oil‐in‐water microemulsion system, consisting of clove oil as oil phase, Tween 20 as surfactant, and water as aqueous phase was developed using a ternary phase diagram. Physicochemical characterization was done to understand the internal physicochemical state. The bulk drug, fluconazole, that measured several microns in length was reduced to a 10–65 nm range with no means of high‐energy methods as confirmed by transmission electron microscopy. The very small and uniform spherical structure of the drug‐loaded microemulsion system could be of high impact to the biological system as the efficacy of fluconazole is greatly improved when compared with its conventional bulk form. The optimized microemulsion exhibited significantly higher antifungal activity at a minimum concentration (8 µg/ml) of fluconazole as examined by fluorescence and scanning electron microscopy. Thus, our report discloses an excellent oral drug delivery system.Keywords
This publication has 50 references indexed in Scilit:
- Overcoming fluconazole resistance in Candida albicans clinical isolates with tetracyclic indolesBioorganic & Medicinal Chemistry Letters, 2012
- Formation of Flavor Oil Microemulsions, Nanoemulsions and Emulsions: Influence of Composition and Preparation MethodJournal of Agricultural and Food Chemistry, 2011
- Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivativesJournal of Controlled Release, 2008
- Inhibition of foodborne pathogens by Hf-1, a novel antibacterial peptide from the larvae of the housefly (Musca domestica) in medium and orange juiceFood Control, 2007
- Epidemiology of Invasive Candidiasis: a Persistent Public Health ProblemClinical Microbiology Reviews, 2007
- An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasisEuropean Journal of Cancer, 2004
- Liquid chromatography–tandem mass spectrometric method for the analysis of fluconazole and evaluation of the impact of phenolic compounds on the concentration of fluconazole in Candida albicansJournal of Pharmaceutical and Biomedical Analysis, 2004
- Molecular basis of resistance to azole antifungalsTrends in Molecular Medicine, 2002
- FluconazoleDrugs, 1995
- Clinical Pharmacokinetics of FluconazoleClinical Pharmacokinetics, 1993